Javascript must be enabled to continue!
GC-MS-based fecal metabolomics reveals gender-attributed fecal signatures in ankylosing spondylitis
View through CrossRef
AbstractAnkylosing spondylitis (AS) has different clinical features in males and females. Fecal metabolites play significant roles in AS disorders. This study aimed to reveal gender-attributed fecal signatures of AS. Fecal samples from 87 cross-sectional individuals (healthy controls: 20 males, 18 females; AS patients: 26 males, 23 females) were analyzed by gas chromatography-mass spectroscopy (GC-MS). Partial least squares discriminant analysis (PLS-DA) was used to reveal differences in the fecal signatures of AS between males and females. Fecal signatures were defined by the significantly different fecal metabolites between AS patients and healthy individuals. Therefore, different fecal signatures of male and female AS patients were defined as gender-attributed fecal signatures. Male-specific fecal signatures in AS patients were steroid compounds, including cholestan-3-ol, tocopherol, stigmastan-3,5-diene, cholest-3-ene, cholest-4-en-6-one and 1-heptatriacotanol. Female-specific fecal signatures were ergost-5-en-3-ol, acetate and D-myo-Inositol. Gender-attributed fecal signatures of AS further reveal differences between males and females in terms of AS features.
Springer Science and Business Media LLC
Title: GC-MS-based fecal metabolomics reveals gender-attributed fecal signatures in ankylosing spondylitis
Description:
AbstractAnkylosing spondylitis (AS) has different clinical features in males and females.
Fecal metabolites play significant roles in AS disorders.
This study aimed to reveal gender-attributed fecal signatures of AS.
Fecal samples from 87 cross-sectional individuals (healthy controls: 20 males, 18 females; AS patients: 26 males, 23 females) were analyzed by gas chromatography-mass spectroscopy (GC-MS).
Partial least squares discriminant analysis (PLS-DA) was used to reveal differences in the fecal signatures of AS between males and females.
Fecal signatures were defined by the significantly different fecal metabolites between AS patients and healthy individuals.
Therefore, different fecal signatures of male and female AS patients were defined as gender-attributed fecal signatures.
Male-specific fecal signatures in AS patients were steroid compounds, including cholestan-3-ol, tocopherol, stigmastan-3,5-diene, cholest-3-ene, cholest-4-en-6-one and 1-heptatriacotanol.
Female-specific fecal signatures were ergost-5-en-3-ol, acetate and D-myo-Inositol.
Gender-attributed fecal signatures of AS further reveal differences between males and females in terms of AS features.
Related Results
Cross-cultural adaptation and validation of Lithuanian questionnaires for the spondyloarthropathies
Cross-cultural adaptation and validation of Lithuanian questionnaires for the spondyloarthropathies
Original English questionnaires – Bath Ankylosing Spondylitis Functional Index, Bath Ankylosing Spondylitis Patient Global Score, and Bath Ankylosing Spondylitis Disease Activity I...
Serum Fetuin-A Level in Patients With Ankylosing Spondylitis and its Relationship With Clinical Parameters
Serum Fetuin-A Level in Patients With Ankylosing Spondylitis and its Relationship With Clinical Parameters
Objectives: This study aims to investigate the association of serum fetuin-A levels with disease activation and clinical parameters in ankylosing spondylitis (AS) patients.
Patien...
Efficacy and Safety of Iguratimod Combined with Yunke Injection in the Treatment of Ankylosing Spondylitis
Efficacy and Safety of Iguratimod Combined with Yunke Injection in the Treatment of Ankylosing Spondylitis
Background
Biologics and Janus kinase (JAK) inhibitors carry specific risks for Ankylosing Spondylitis patients at risk of tuberculosis infection or those with co...
AYURVEDIC MANAGEMENT OF ANKYLOSING SPONDYLITIS – A CASE REPORT
AYURVEDIC MANAGEMENT OF ANKYLOSING SPONDYLITIS – A CASE REPORT
Ankylosing spondylitis (AS) is a chronic, systemic, inflammatory disease that affects primarily sacroiliac joints and the spine. It is a gradually progressive condition over severa...
Neutrophil/lymphocyte and platelet/lymphocyte ratios as potential markers of disease activity in patients with Ankylosing spondylitis: a case-control study
Neutrophil/lymphocyte and platelet/lymphocyte ratios as potential markers of disease activity in patients with Ankylosing spondylitis: a case-control study
Abstract
Background
The neutrophil/ lymphocyte ratio (NLR) and platelet/lymphocyte ratio (PLR) have the potential to be inflammatory markers that re...
Turkish Version of Evaluation of Ankylosing Spondylitis Quality of Life Questionnaire in Patients With Ankylosing Spondylitis: A Validation and Reliability Study
Turkish Version of Evaluation of Ankylosing Spondylitis Quality of Life Questionnaire in Patients With Ankylosing Spondylitis: A Validation and Reliability Study
Objectives: This study aims to translate the Evaluation of Ankylosing Spondylitis Quality of Life (EASi-QoL) into the Turkish language and test its validity and reliability.
Patie...
Aryl hydrocarbon receptor gene expression in ankylosing spondylitis and its correlation with interleukin-17, RAR-related orphan receptor gamma t expression, and disease activity indices
Aryl hydrocarbon receptor gene expression in ankylosing spondylitis and its correlation with interleukin-17, RAR-related orphan receptor gamma t expression, and disease activity indices
Objectives: Considering the role of T helper (Th)17 cells in the pathogenesis of ankylosing spondylitis (AS), the aim of this study was to determine the correlation between aryl hy...
A Statewide Study of Cardiovascular Outcomes in Patients with Ankylosing Spondylitis
A Statewide Study of Cardiovascular Outcomes in Patients with Ankylosing Spondylitis
Numerous studies have shown that ankylosing spondylitis is associated with an increased risk of cardiovascular disease including heart failure, acute myocardial infarction, stroke,...

